Showing results (201-210 of 246) with videos related to

Sort By:
Pageof 25
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2017
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancerR Condorelli, L Spring, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2006
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancerF Andre, N Cabioglu, H Assi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 15, 2018
Endocrine therapy or chemotherapy as first-line therapy in hormone receptor-positive HER2-negative metastatic breast cancer patientsE Jacquet, A Lardy-Cléaud, B Pistilli, et al.
ESMO Open|February 13, 2024
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomesM A Franzoi, M Aupomerol, J Havas, et al.
Ecology and Evolution|April 22, 2017
How repeatable is the Environmental Impact Classification of Alien Taxa (EICAT)? Comparing independent global impact assessments of amphibiansSabrina Kumschick, G John Measey, Giovanni Vimercati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2025
Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: final overall survival analysis of the phase 3 TROPION-Breast01 studyB Pistilli, K Jhaveri, S-A Im, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcomeJ-P Spano, F Andre, L Morat, et al.
ESMO Open|July 25, 2021
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME)D Dano, A Lardy-Cleaud, A Monneur, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2007
Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancerF Meslin, R Conforti, C Mazouni, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2019
A phase Ib dose allocation study of oral administration of lucitanib given in combination with fulvestrant in patients with estrogen receptor-positive and FGFR1-amplified or non-amplified metastatic breast cancerM Campone, T Bachelot, F Penault-Llorca, et al.
Pageof 25